细胞表面标记检测市场：按产品、按应用、按地区 - 规模、份额、展望、机会分析，2023-2030 年

细胞表面标记物检测是使用流式细胞仪等分析技术和流程分离和鑑定目标细胞。 使用流式细胞术等技术的细胞表面标记分析有望简化疾病分析、样本分离、疾病诊断和后续治疗决策。

市场动态：

与疾病诊断中细胞表面标誌物的使用增加、癌症患病率上升、流式细胞术在干细胞研究中的采用增加、对精准医学的需求增加、通量和自动化的增加有关技术进步是预计推动增长的主要因素全球细胞表面标记检测市场。

例如，2022 年 4 月，血液学、尿液分析和止血领域的自动化工作流程解决方案提供商 Sysmex Europe 获得了流式细胞仪 XF 的 CE 标誌，表明符合欧洲 IVD 法规和 IVD 应用。- 1600 推出，为流式细胞术实验室建立完整的解决方案，以帮助自动化和优化工作流程，以达到新的效率水平。

这项研究的主要特点

• 本报告对全球细胞表面标记检测市场进行了深入分析，提供了以 2022 年为基准年的预测期 (2023-2030) 的市场规模和復合年增长率 (CAGR%)。I在这里。
• 它还阐明了各个细分市场的潜在创收机会，并描述了该市场具有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 它根据以下参数（包括公司亮点、产品组合、主要亮点、财务业绩和战略）介绍了全球细胞表面标记检测市场的领先企业。
• 参与这项研究的主要公司包括 Grifols SA、Abbott Laboratories、Sysmex Corporation、Agilent Technologies Inc.、Nexcelom Bioscience、Thermo Fisher Scientific Inc.、Siemens Healthineers、Nihon Kohden Corporation、F. Hoffmann -La Roche Ltd。 、Bio Rad Laboratories Inc.、Becton, Dickinson and Company (BD)、Qiagen NV、Diasorin SpA (Luminex Corporation)、Danaher Corporation (Beckman Coulter Inc.)、IVD Medical Holding Limited (Immucor Inc.) 等。
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 《全球细胞表面标记物检测市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球细胞表面标记物检测市场的各种战略矩阵来促进决策制定。

内容

第一章调查的目的和前提

• 调查目的
• 先决条件
• 缩写说明

第二章市场范围

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况，按产品分类
  • 市场概况：按应用分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

• 市场动态
  • 使用细胞表面标记物进行疾病诊断的人数增加
  • 昂贵的设备和缺乏熟练的专业人员
  • 全球癌症患病率上升
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/批准
• 害虫分析
• 对 PORTER 的分析
• 合併/收购场景

第 4 章全球细胞表面标记物检测市场 - 冠状病毒 (COVID-19) 大流行的影响

• COVID-19 流行病学
• 供应方和需求方分析
• 经济影响

第 5 章全球细胞表面标记检测市场，按产品分类，2017-2030

• 流式细胞术
• 血液分析仪
• 细胞成像系统
• 试剂和试剂盒
• 其他产品

第 6 章全球细胞表面标记物检测市场，按应用，2017-2030

• 疾病诊断与鑑定
• 药物发现
• 其他 - 研究和学术应用

第 7 章全球细胞表面标记物检测市场，按地区划分，2017-2030

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲
• 世界其他地区

第八章竞争格局

• Grifols SA
• Abbott Laboratories
• Sysmex Corporation
• Agilent Technologies Inc.
• Nexcelom Bioscience
• Thermo Fisher Scientific Inc.
• Siemens Healthineers
• Nihon Kohden Corporation
• F. Hoffmann-La Roche Ltd.
• Bio Rad Laboratories Inc.
• Becton, Dickinson and Company（BD）
• Qiagen NV
• Diasorin SpA（Luminex Corporation）
• Danaher Corporation（Beckman Coulter Inc.）
• IVD Medical Holding Limited（Immucor Inc.）

第 9 章

• 调查方法
• 关于出版商

Cell surface markers detection refers to separation and identification of target cells using analytical methods and processes, such as flow cytometry. Cell surface marker analysis through the usage of technologies, such as flow cytometry, is expected to simplify disease analysis, sample separation, disease diagnosis, and subsequent treatment determination.

Market Dynamics:

Rise in use of cell surface markers in disease diagnostics, rise in prevalence of cancer, increasing adoption of flow cytometry in stem cell research, increasing demand for precision medicine, and technological advances related to increased throughput and automation are major factors expected to drive growth of the global cell surface markers detection market.

For instance, in April 2022, Sysmex Europe, a provider of automated workflow solutions in the disciplines of hematology, urinalysis, and hemostasis, launched Flow Cytometer XF-1600 which has received CE marking, indicating its compliance with the European IVD Regulation and IVD use; establishing a complete solution for flow cytometry laboratories to help them automate and optimize their workflow for a new level of efficiency.

Key features of the study:

• This report provides in-depth analysis of the global cell surface markers detection market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cell surface markers detection market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cell surface markers detection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell surface markers detection market.

Detailed Segmentation:

• Global Cell Surface Markers Detection Market, By Product:
  • Flow Cytometry
  • Hematology Analysers
  • Cell Imaging Systems
  • Reagents and Kits
  • Other Products
• Global Cell Surface Markers Detection Market, By Application:
  • Disease Diagnosis and Identification
  • Drug Discovery
  • Other - Research and Academia Applications
• Global Cell Surface Markers Detection Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Grifols SA
  • Abbott Laboratories
  • Sysmex Corporation
  • Agilent Technologies Inc.
  • Nexcelom Bioscience
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Nihon Kohden Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bio Rad Laboratories Inc.
  • Becton, Dickinson and Company (BD)
  • Qiagen NV
  • Diasorin SpA (Luminex Corporation)
  • Danaher Corporation (Beckman Coulter Inc.)
  • IVD Medical Holding Limited (Immucor Inc.)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in use of cell surface markers disease diagnostics
  • High cost of instruments and dearth of skilled professionals
  • Rise in prevalence of cancer worldwide
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Cell Surface Markers Detection Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Cell Surface Markers Detection Market, By Product, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Flow Cytometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Hematology Analysers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Cell Imaging Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Reagents and Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Other Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Cell Surface Markers Detection Market, By Application, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Disease Diagnosis and Identification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Other - Research and Academia Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Cell Surface Markers Detection Market, By Geography, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

8. Competitive Landscape

• Grifols SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sysmex Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nexcelom Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nihon Kohden Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company (BD)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen NV
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Diasorin SpA (Luminex Corporation)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation (Beckman Coulter Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IVD Medical Holding Limited (Immucor Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us